Zone 2 cardiosupports
“Solid mechanism. Hard to argue with.”
2024-07-15 · Substack 2024-07View on protocol →
MIT Aging Center
Biochemist; runs a lab on cellular senescence and mTOR signaling.
Hover any dot to read the position. Click to jump to the card below.
Across the protocols both they and we cover.
Defaults to 'mouse data ≠ human data' until trial evidence arrives.
Quotes specific HRs and CIs rather than vibes.
Holds priors carefully; reversals are documented over months.
“Solid mechanism. Hard to argue with.”
“Likely brain benefits too.”
“Highest-leverage non-pharma intervention.”
“Promising, but human evidence is thin.”